Ms. Wold has served as a member of our board of directors since May 2010. She is Chief Executive Officer of the Church Pension Fund, which oversees defined benefit and defined contribution pension plans for clergy and lay employees of the Episcopal Church. She was previously senior vice president of finance, senior vice president of tax and treasury and vice president of tax at Wyeth, and with the international law firm of Shearman & Sterling based in New York. Ms. Wold received her law degree from the University of Michigan. She was appointed Vice Chairman and Lead Independent Director of Unilife in 2015. She is the chair of the Strategic Partnerships Committee and serves on the Audit Committee and the Nominating and Governance Committee.
Ms. Crane has served as a member of our Board of Directors since October 2016. Ms. Crane is an experienced life sciences executive who previously served as President and Chief Executive Officer of Epocrates, Inc. Prior to leading Epocrates, she held senior executive positions at Johnson & Johnson, including Group Chairman, OTC & Nutritional Group, Group Chairman, Consumer, Specialty Pharmaceuticals and Nutritionals, and Executive Vice President of Global Marketing for the Pharmaceutical Group. Ms. Crane has also served in executive roles at Bristol-Myers Squibb, including President of U.S. Primary Care and President of Global Marketing and Consumer Products. She presently serves as a Director of Teva Pharmaceuticals and as Vice Chairman of the Board of Zealand Pharma A/S. Ms. Crane received her MBA from Kent State University and her BA in Communications and English from the State University of New York.
Mr. DeSisto has served as a member of our Board of Directors since October 2016. Mr. DeSisto most recently served as the President and Chief Executive Officer of Insulet Corporation from 2003 to 2014, after serving as Insulet’s Acting Chief Executive Officer and Chief Financial Officer and Treasurer. Prior to his executive roles at Insulet, Mr. DeSisto was President, Chief Executive Officer and Chief Financial Officer of PaperExchange.com, Inc., Chief Financial Officer of FGX International Holdings Limited (formerly AAI-Foster Grant, Inc.), and Chief Financial Officer of ZOLL Medical Corporation. Mr. DeSisto received his MBA from Bryant College and his BS from Providence College.
Mr. Hamill has served as a member of our board of directors since August 2015. Mr. Hamill is an experienced financial executive in the public company life sciences sector, who prior to his retirement held several senior finance positions at Wyeth. During Mr. Hamill’s 18-year career at Wyeth, he held various executive roles, including leading global Mergers and Acquisitions, Vice-President Finance for Wyeth’s global manufacturing and distribution operations, CFO of a global animal health business unit, and Corporate Vice President and Deputy Controller. Prior to his career at Wyeth, Mr. Hamill was a Partner at a large regional public accounting firm. He is a Certified Public Accountant and a graduate of Baruch College.
Dr. Kamarck has server as a member of our Board of Directors since July 2016. Dr. Kamarck is an experienced life sciences executive who most recently served as President of Merck BioVentures and Senior Vice President of Vaccines and Biologics Manufacturing for Merck. From 2001 to 2009, he held various senior executive positions at Wyeth, including President, Technical Operations and Product Supply and was responsible for global technical operations for all of Wyeth’s businesses. Dr. Kamarck also served as a member of the Wyeth Management Committee. Prior to Wyeth, he was employed by Bayer AG for 17 years in a variety of technical and leadership capacities. Dr. Kamarck received his B.A. from Oberlin College and his Ph.D. from the Massachusetts Institute of Technology in Biochemistry, and he was a Leukemia Society Fellow at Yale University.
Mr. Lund has served as a member of our board of directors since November 2009. He is a managing partner of M&A Holdings, LLC, a private consulting company and Upstart CFO. He has previously held senior finance and corporate controller roles with public and private companies, and was also a manager at KPMG. Mr. Lund is chair of the Unilife Audit Committee and is a member of the Strategic Partnerships, Compensation, and Nominating and Corporate Governance Committees.
= Chair of the Board
= Independent Director